A Phase 3, multi-center, prospective, randomized, double-blind, placebo- controlled study to evaluate the effectiveness and safety of ZP5-9676 for the treatment of Hookworm (Ancylostoma duodenale and Necator americanus), Ascaris lumbricoides, and Trichuris trichiura in pediatric and adult Participants

计划入组 300 人

Phase 3, Multi-center, Prospective, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Effectiveness and Safety of ZP5-9676 for the Treatment of Soil Transmitted Helminthiasis (STH)

计划入组 300 人 · 首次发布于 2023 年 11 月 13 日

Monitoring the Efficacy of Anthelmintics for the Treatment of Soil Transmitted Helminths P2

计划入组 250 人 · 首次发布于 2011 年 6 月 23 日

EMA Safety Committee Initiates Review of Levamisole Following Fatal Leukoencephalopathy Case

EMA Recommends Withdrawal of Levamisole Medicines from EU Market Due to Serious Brain Side Effects

Albendazole-Ivermectin Combination Shows Promise Against Intestinal Worms in Phase II/III Trial